Department of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK
University College London, London, UK.
Int J Gynecol Cancer. 2024 Sep 2;34(9):1334-1343. doi: 10.1136/ijgc-2024-005756.
Standard of care genetic testing has undergone significant changes in recent years. The British Gynecological Cancer Society and the British Association of Gynecological Pathologists (BGCS/BAGP) has re-assembled a multidisciplinary expert consensus group to update the previous guidance with the latest standard of care for germline and tumor testing in patients with ovarian cancer. For the first time, the BGCS/BAGP guideline group has incorporated a patient advisor at the initial consensus group meeting. We have used patient focused groups to inform discussions related to reflex tumor testing - a key change in this updated guidance. This report summarizes recommendations from our consensus group deliberations and audit standards to support continual quality improvement in routine clinical settings.
近年来，标准护理基因检测发生了重大变化。英国妇科癌症学会和英国妇科病理学家协会（BGCS/BAGP）重新组建了一个多学科专家共识小组，根据最新的标准护理，对卵巢癌患者的种系和肿瘤检测进行了更新。这是 BGCS/BAGP 指南小组首次在最初的共识小组会议上纳入了患者顾问。我们利用以患者为中心的小组来告知与反射肿瘤检测相关的讨论-这是本更新指南中的一个关键变化。本报告总结了我们共识小组审议和审核标准的建议，以支持常规临床环境中的持续质量改进。
